Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysisPatricia Cortazar, Gϋnter von Minckwitz, Luca Gianni et al.|The Lancet|2014Cited by 4.7k
FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based ChemotherapyDickran Kazandjian, Richard Pazdur, Gideon M. Blumenthal et al.|The Oncologist|2016Cited by 478
A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumorsGideon M. Blumenthal, Phillip A. Dennis|Oncotarget|2014Cited by 39
Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysisKelly J. Norsworthy, David J. Graham, Armen Avagyan et al.|Leukemia|2020Cited by 32